Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement
NCT: NCT03247023 · TERMINATED
Brief Summary
This study will evaluate the long term performance and safety data for the Cadence™ Total Ankle System (CTAS) when used for primary arthroplasty in patients with primary arthritis (e.g. degenerative disease), secondary arthritis (e.g. post-traumatic, avascular necrosis, if minimally 2/3 of the talus is preserved), and systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis)
Frequently Asked Questions
What is Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement?
Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement is a clinical trial registered under NCT03247023. Current status: TERMINATED.
What is the status of NCT03247023?
The current status of NCT03247023 (Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement) is: TERMINATED.
When did Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement start?
Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement started on 2017-09-18.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.